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Abstract 
The induction of robust allograft tolerance is the ultimate goal for clinical transplantation. 
Although studies have identified that dendritic cells (DCs) are important for induction of 
antigen-specific tolerance, the requirements for generating tolerogenic DCs are yet to be 
elucidated. Recently, it has been demonstrated the modulation of two signaling pathways, 
Notch and nuclear factor KB (NF-KB) can render DCs tolerogenic. The studies documented 
here examine (1) whether immature DCs over-expressing Notch-related molecules (Jagged-I, 
Delta-like-I (Dll-I), Lunatic Fringe (Ung) , and Manic Fringe (Mfng)) act as 
immunoregulatory DCs and promote allograft survival; and (2) whether DCs deficient in 
NF-KB signaling inhibit the alloreactive T cell response and promote allograft survival. 
The immature DC cell line (JAWS II cells (H_2b)) was retrovirally transduced to 
over-express murine (m)Jagged-I, mDII-I, mUng, or mMfng. JAWS II cells 
over-expressing Notch related molecules remained immature following transduction, 
however, these cells were unable to modulate an alloreactive T cell (H_2k) response in vitro. 
Pretreatment of allogeneic CBNH mice (H_2k) with transduced JAWS II cells failed to 
promote C57BLl6 (H_2b) thyroid allograft survival. Cellular transplantation of JAWS II cells 
over-expressing Notch related molecules were also acutely rejected in CBNH mice 
suggesting lack of immunomodulation by genetically engineered JAWS II cells in vivo. In 
addition, cellular grafts of JAWS II cells to H-2-compatible mice (H_2b) were chronically 
rejected, indicating that JAWS II cells and C57BLl6 mice differ at one or more minor 
histocompatibility loci. 
The NF-KB inhibitor, BAYll-7082 (BAY), and cRel inhibitor, Pentoxifylline (Ptx), were 
used to prevent NF-KB signaling in C57BLl6 (H_2b) splenocytes and bone marrow-derived 
DCs (BMDCs). BAY treatment abrogated the capacity of splenocytes (and to a lesser extent 
Vll 
--
BMDCs) to stimulate allogeneic (H_2k) T cells. This effect correlated with reduced 
expression of costimulatory molecules and major histocompatibility complex (MHC) Class 
II molecules on the treated splenocyte and BMDC population. It was also shown that 
BAY-treated splenocytes did not produce inflammatory cytokines including interferon 
(IFN)-y, tumor necrosis factor (TNF)-Cl, IL-2 and IL-4, and produced less IL-5 compared to 
untreated splenocytes. Although allogeneic T cells did not proliferate in response to 
BAY-treated splenocytes, subsequent T cell proliferation in response to a secondary stimulus 
was observed in vitro . T cells previously exposed to BAY-treated splenocytes also failed to 
inhibit naIve T cell proliferation indicating lack of regulatory T cell differentiation. 
Based on the finding that BAY treatment inhibited the capacity of APCs to induce 
alloreactive T cell proliferation in vitro, we examined whether BAY treatment of thyroid 
tissue or adult islets prior to transplantation inhibited the immunostimulatory capacity of 
donor passenger leukocytes to prime recipient T cells. Allografts precultured with BAY were 
rejected with similar kinetics to control cultured allografts, indicating that in vitro exposure 
to BAY was not sufficient to prevent alloreactive T cell activation by donor passenger 
leukocytes. However, CBNH (H_2k) mice which received BAY-treated splenocytes or 
BAY-treated BMDCs intravenously prior to implantation of C57BLl6 (H_2b) thyroid tissue 
demonstrated prolonged allograft survival. This finding indicates that an in vivo environment 
provides additional signal(s) which are absent in the in vitro system and which are necessary 
for modulating alloresponses. The mechanism by which BAY splenocytes and BAY BMDCs 
prolong allograft survival requires further investigation. 
Although the potential for Notch signaling to promote alloantigen-specific tolerance remains 
unresolved, these studies suggest that inhibition of NF-KB signaling in DCs represent a 
potential approach for promoting allograft survival. 
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